Articles about VG Somani

Sleeves up! Coronavirus vaccination drive could begin on January 13

05 Jan 2021

India
Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

05 Jan 2021

India
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

All you need to know about vaccines approved in India

03 Jan 2021

India
All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

03 Jan 2021

India
SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.

Coronavirus: India's daily death toll remained under 300 last week

01 Jan 2021

India
Coronavirus: India's daily death toll remained under 300 last week

India recorded less than 300 deaths linked to coronavirus every day between last Thursday and today, the government said.

India set to start COVID-19 vaccination; panel approves Oxford vaccine

01 Jan 2021

India
India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

India could start 2021 with COVID-19 vaccine in hand: DCGI

31 Dec 2020

India
India could start 2021 with COVID-19 vaccine in hand: DCGI

The approval for a COVID-19 vaccine in India is likely just around the corner, with the Drugs Controller General of India, Dr. VG Somani, indicating the country might begin the New Year with a vaccine in hand.

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

16 Sep 2020

India
After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

12 Sep 2020

India
Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

10 Sep 2020

India
Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

SII gets nod for Oxford COVID vaccine phase 2/3 trials

03 Aug 2020

India
SII gets nod for Oxford COVID vaccine phase 2/3 trials

The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.

Remdesivir reportedly approved for COVID-19 treatment in India

02 Jun 2020

India
Remdesivir reportedly approved for COVID-19 treatment in India

Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.